Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas

C. Tang, I. Biemond, G. J A Offerhaus, W. Verspaget, C. B H W Lamers

Research output: Contribution to journalArticle

Abstract

Gut hormones that modulate the growth of normal pancreas may also modulate the growth of cancers originating from pancreas. This study visualized and compared the receptors for cholecystokinin (CCK), bombesin (BBS), secretin and vasoactive intestinal peptide (VIP) in tumour-free tissue sections of human pancreas (n = 10) and pancreatic ductal adenocarcinomas (n = 12) with storage phosphor autoradiography using radioligands. CCK-B receptors, present in control pancreata, were not detected in any of the pancreatic cancers. BBS receptors were visualized in control pancreata, but they were absent in 10 of 12 pancreatic cancers. In 5 of 12 pancreatic cancers, receptors for secretin were visualized, while binding for secretin was present in all tumour-free pancreata. Conversely, no specific binding of VIP was detected in control pancreata but was identified in 3 of 12 pancreatic cancer specimens. It is concluded that the expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas. Receptors for these peptides are present in only a minority of pancreatic cancer specimens.

Original languageEnglish (US)
Pages (from-to)1467-1473
Number of pages7
JournalBritish Journal of Cancer
Volume75
Issue number10
StatePublished - 1997
Externally publishedYes

Fingerprint

Peptide Receptors
Pancreatic Neoplasms
Pancreas
Adenocarcinoma
Neoplasms
Bombesin Receptors
Secretin
Vipoma
Cholecystokinin B Receptor
Cholecystokinin Receptors
Vasoactive Intestinal Peptide
Autoradiography
Growth Hormone
Growth

Keywords

  • Gut peptide
  • Pancreatic cancer
  • Receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tang, C., Biemond, I., Offerhaus, G. J. A., Verspaget, W., & Lamers, C. B. H. W. (1997). Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. British Journal of Cancer, 75(10), 1467-1473.

Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. / Tang, C.; Biemond, I.; Offerhaus, G. J A; Verspaget, W.; Lamers, C. B H W.

In: British Journal of Cancer, Vol. 75, No. 10, 1997, p. 1467-1473.

Research output: Contribution to journalArticle

Tang, C, Biemond, I, Offerhaus, GJA, Verspaget, W & Lamers, CBHW 1997, 'Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas', British Journal of Cancer, vol. 75, no. 10, pp. 1467-1473.
Tang C, Biemond I, Offerhaus GJA, Verspaget W, Lamers CBHW. Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. British Journal of Cancer. 1997;75(10):1467-1473.
Tang, C. ; Biemond, I. ; Offerhaus, G. J A ; Verspaget, W. ; Lamers, C. B H W. / Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. In: British Journal of Cancer. 1997 ; Vol. 75, No. 10. pp. 1467-1473.
@article{639040c7ca9f4e62a8e3ec138bea989c,
title = "Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas",
abstract = "Gut hormones that modulate the growth of normal pancreas may also modulate the growth of cancers originating from pancreas. This study visualized and compared the receptors for cholecystokinin (CCK), bombesin (BBS), secretin and vasoactive intestinal peptide (VIP) in tumour-free tissue sections of human pancreas (n = 10) and pancreatic ductal adenocarcinomas (n = 12) with storage phosphor autoradiography using radioligands. CCK-B receptors, present in control pancreata, were not detected in any of the pancreatic cancers. BBS receptors were visualized in control pancreata, but they were absent in 10 of 12 pancreatic cancers. In 5 of 12 pancreatic cancers, receptors for secretin were visualized, while binding for secretin was present in all tumour-free pancreata. Conversely, no specific binding of VIP was detected in control pancreata but was identified in 3 of 12 pancreatic cancer specimens. It is concluded that the expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas. Receptors for these peptides are present in only a minority of pancreatic cancer specimens.",
keywords = "Gut peptide, Pancreatic cancer, Receptor",
author = "C. Tang and I. Biemond and Offerhaus, {G. J A} and W. Verspaget and Lamers, {C. B H W}",
year = "1997",
language = "English (US)",
volume = "75",
pages = "1467--1473",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas

AU - Tang, C.

AU - Biemond, I.

AU - Offerhaus, G. J A

AU - Verspaget, W.

AU - Lamers, C. B H W

PY - 1997

Y1 - 1997

N2 - Gut hormones that modulate the growth of normal pancreas may also modulate the growth of cancers originating from pancreas. This study visualized and compared the receptors for cholecystokinin (CCK), bombesin (BBS), secretin and vasoactive intestinal peptide (VIP) in tumour-free tissue sections of human pancreas (n = 10) and pancreatic ductal adenocarcinomas (n = 12) with storage phosphor autoradiography using radioligands. CCK-B receptors, present in control pancreata, were not detected in any of the pancreatic cancers. BBS receptors were visualized in control pancreata, but they were absent in 10 of 12 pancreatic cancers. In 5 of 12 pancreatic cancers, receptors for secretin were visualized, while binding for secretin was present in all tumour-free pancreata. Conversely, no specific binding of VIP was detected in control pancreata but was identified in 3 of 12 pancreatic cancer specimens. It is concluded that the expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas. Receptors for these peptides are present in only a minority of pancreatic cancer specimens.

AB - Gut hormones that modulate the growth of normal pancreas may also modulate the growth of cancers originating from pancreas. This study visualized and compared the receptors for cholecystokinin (CCK), bombesin (BBS), secretin and vasoactive intestinal peptide (VIP) in tumour-free tissue sections of human pancreas (n = 10) and pancreatic ductal adenocarcinomas (n = 12) with storage phosphor autoradiography using radioligands. CCK-B receptors, present in control pancreata, were not detected in any of the pancreatic cancers. BBS receptors were visualized in control pancreata, but they were absent in 10 of 12 pancreatic cancers. In 5 of 12 pancreatic cancers, receptors for secretin were visualized, while binding for secretin was present in all tumour-free pancreata. Conversely, no specific binding of VIP was detected in control pancreata but was identified in 3 of 12 pancreatic cancer specimens. It is concluded that the expression of gut peptide receptors in pancreatic cancer differs from that in tumour-free pancreas. Receptors for these peptides are present in only a minority of pancreatic cancer specimens.

KW - Gut peptide

KW - Pancreatic cancer

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=0030975685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030975685&partnerID=8YFLogxK

M3 - Article

C2 - 9166939

AN - SCOPUS:0030975685

VL - 75

SP - 1467

EP - 1473

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 10

ER -